These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37248323)
21. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension. Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566 [TBL] [Abstract][Full Text] [Related]
22. C-atrial natriuretic peptide (ANP) Lu YY; Li SJ; Zhang Z; He S; Guo YT; Hong MN; Shao S; Wang RQ; Zhang J; Wang JG; Gao PJ; Li XD Exp Cell Res; 2023 Oct; 431(1):113738. PubMed ID: 37572787 [TBL] [Abstract][Full Text] [Related]
23. Dietary Potassium Supplementation Reduces Chronic Kidney Lesions Independent of Blood Pressure in Deoxycorticosterone-Acetate and High Sodium Chloride-Treated Mice. Wang Q; Schäfer SC; Haefliger JA; Maillard MP; Alonso F Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069178 [TBL] [Abstract][Full Text] [Related]
24. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury. Chen M; Wen X; Gao Y; Liu B; Zhong C; Nie J; Liang H Int Immunopharmacol; 2021 Nov; 100():108142. PubMed ID: 34555644 [TBL] [Abstract][Full Text] [Related]
25. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats. Lee TM; Chung TH; Lin SZ; Chang NC J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935 [TBL] [Abstract][Full Text] [Related]
26. Tumor Necrosis Factor Alpha Deficiency Improves Endothelial Function and Cardiovascular Injury in Deoxycorticosterone Acetate/Salt-Hypertensive Mice. Cai R; Hao Y; Liu YY; Huang L; Yao Y; Zhou MS Biomed Res Int; 2020; 2020():3921074. PubMed ID: 32190663 [TBL] [Abstract][Full Text] [Related]
27. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene. Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026 [TBL] [Abstract][Full Text] [Related]
28. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension. Manhiani M; Quigley JE; Knight SF; Tasoobshirazi S; Moore T; Brands MW; Hammock BD; Imig JD Am J Physiol Renal Physiol; 2009 Sep; 297(3):F740-8. PubMed ID: 19553349 [TBL] [Abstract][Full Text] [Related]
29. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Wang Y; Wang DH Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112 [TBL] [Abstract][Full Text] [Related]
30. Finerenone Reduces Renal RORγt γδ T Cells and Protects against Cardiorenal Damage. Luettges K; Bode M; Diemer JN; Schwanbeck J; Wirth EK; Klopfleisch R; Kappert K; Thiele A; Ritter D; Foryst-Ludwig A; Kolkhof P; Wenzel UO; Kintscher U Am J Nephrol; 2022; 53(7):552-564. PubMed ID: 35675794 [TBL] [Abstract][Full Text] [Related]
31. Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice. Krishnan SM; Dowling JK; Ling YH; Diep H; Chan CT; Ferens D; Kett MM; Pinar A; Samuel CS; Vinh A; Arumugam TV; Hewitson TD; Kemp-Harper BK; Robertson AA; Cooper MA; Latz E; Mansell A; Sobey CG; Drummond GR Br J Pharmacol; 2016 Feb; 173(4):752-65. PubMed ID: 26103560 [TBL] [Abstract][Full Text] [Related]
32. Role of substance P in renal injury during DOCA-salt hypertension. Wang Y; Wang DH Endocrinology; 2012 Dec; 153(12):5972-9. PubMed ID: 23024265 [TBL] [Abstract][Full Text] [Related]
33. Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice. Tian M; Tang L; Wu Y; Beddhu S; Huang Y Am J Physiol Renal Physiol; 2018 Sep; 315(3):F558-F571. PubMed ID: 29873514 [TBL] [Abstract][Full Text] [Related]
34. GPR97 deficiency ameliorates renal interstitial fibrosis in mouse hypertensive nephropathy. Wu JC; Wang XJ; Zhu JH; Huang XY; Liu M; Qiao Z; Zhang Y; Sun Y; Wang ZY; Zhan P; Zhang T; Hu HL; Liu H; Tang W; Yi F Acta Pharmacol Sin; 2023 Jun; 44(6):1206-1216. PubMed ID: 36635422 [TBL] [Abstract][Full Text] [Related]
35. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway. Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237 [TBL] [Abstract][Full Text] [Related]
36. ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway. Chen Z; Wu C; Liu Y; Li H; Zhu Y; Huang C; Lin H; Qiao Q; Huang M; Zhu Q; Wang L Cell Death Dis; 2020 Aug; 11(8):698. PubMed ID: 32829380 [TBL] [Abstract][Full Text] [Related]
37. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes. Amador CA; Barrientos V; Peña J; Herrada AA; González M; Valdés S; Carrasco L; Alzamora R; Figueroa F; Kalergis AM; Michea L Hypertension; 2014 Apr; 63(4):797-803. PubMed ID: 24420551 [TBL] [Abstract][Full Text] [Related]
38. Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats. Bae EH; Kim IJ; Ma SK; Kim SW Hypertens Res; 2010 Mar; 33(3):255-62. PubMed ID: 20057489 [TBL] [Abstract][Full Text] [Related]
39. Brain endoplasmic reticulum stress mechanistically distinguishes the saline-intake and hypertensive response to deoxycorticosterone acetate-salt. Jo F; Jo H; Hilzendeger AM; Thompson AP; Cassell MD; Rutkowski DT; Davisson RL; Grobe JL; Sigmund CD Hypertension; 2015 Jun; 65(6):1341-8. PubMed ID: 25895586 [TBL] [Abstract][Full Text] [Related]
40. Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension. Hisamichi M; Kamijo-Ikemori A; Sugaya T; Ichikawa D; Natsuki T; Hoshino S; Kimura K; Shibagaki Y FASEB J; 2017 Jan; 31(1):72-84. PubMed ID: 27663860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]